tiprankstipranks
Trending News
More News >
3D Medicines, Inc. (HK:1244)
:1244
Hong Kong Market

Compare 3D Medicines, Inc. (1244) vs. Competitors

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
3D Medicines, Inc.
HK$6.14
HK$1.23B
-6.40
70.86%
Brii Biosciences Limited
HK$1.44
HK$1.09B
-2.71
34.82%
Genor Biopharma Holdings Limited
HK$3.06
HK$5.02B
56.31
32.98%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.18B
392.38
116.84%
JW (Cayman) Therapeutics Co. Ltd.
HK$2.50
HK$1.01B
-1.48
74.10%
Transcenta Holding Limited
HK$2.25
HK$1.05B
-3.36
332.73%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1244
3D Medicines, Inc.
4.75
1.98
71.48%
HK:2137
Brii Biosciences Limited
1.51
0.43
39.81%
HK:6998
Genor Biopharma Holdings Limited
2.50
0.62
32.98%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.12
2.28
123.91%
HK:2126
JW (Cayman) Therapeutics Co. Ltd.
2.42
1.01
71.63%
HK:6628
Transcenta Holding Limited
2.38
1.82
325.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts